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The CTCF transcription factor is thought to be one of the main participants in various gene regulatory net-
works including transcription activation and repression, formation of independently functioning chromatin do-
mains, regulation of imprinting etc. Sequencing of human and other genomes opened up a possibility to ascer-
tain the genomic distribution of CTCF binding sites and to identify CTCF-dependent cis-regulatory elements, in-
cluding insulators. In the review, we summarized recent data on CTCF functioning within a framework of the
chromatin loop domain hypothesis of large-scale regulation of the genome activity. Its fundamental properties
allow CTCF to serve as a transcription factor, an insulator protein and a dispersed genome-wide demarcation
tool able to recruit various factors that emerge in response to diverse external and internal signals, and thus to
exert its signal-specific function(s).
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Introduction. CCCTC binding factor (CTCF) is an evo-
lutionally conserved transcription factor of vertebrates.
It binds to different functional elements of the genome
and performs various regulatory functions (see recent
reviews [1–3]).
The transcription factor CTCF was first identified
as a protein able to recognize the sequence of three direct
CCCTC repeats in the regulatory region of chickenMYC
gene [4, 5]. Concurrently, the NeP1 protein binding to
F1 element of the chicken lysozyme silencer was descri-
bed [6]. NeP1 and CTCF were later found to be the same
protein [7].
The primary structure of CTCF is highly conserved;
CTCF orthologs were revealed in different vertebrates:
humans, dogs, mice, chickens, frogs, etc. [8–10]. The
amino acid (a. a.) sequences of human and chicken
CTCF proteins are 93 % identical [11].
Human CTCF polypeptide chain consists of 727 a. a.
The central DNA-binding domain contains eleven zinc
fingers, which are flanked by lysine- and arginine-rich
positively charged N- and C-terminal domains of 267
and 150 a. a. [12]. Following DNA-binding domain the-
re is a glycine-rich motif typical for both ATP- and GTP-
binding proteins. The nuclear localization signal is lo-
cated closer to the C-terminus of the polypeptide, the
phosphorylation sites are next to it [9, 11].
The variety of functions of CTCF protein presumes
that there is the process of regulation of the CTCF acti-
vity, performed, inter alia, via its posttranslational mo-
difications. Noteworthy are such modifications as the
phosphorylation by casein kinase 2 [13], ADP-ribosy-
lation [14], and sumoylation [15–17].
In the course of evolution, CTCF appears in bilate-
ral metazoa and is absent in plants and protozoa [18].
CTCF is constitutively expressed and required for the
functioning of many vertebrate cell types in the multi-
cellular organism. It is likely that CTCF is not required
for the growth of mammalian cells in culture [2].
However, the significance of CTCF protein for the
development of vertebrates is evidenced by the fact that
murine embryos, homozygous for the knocked outCTCF
gene, died prior to the implantation [19, 20]. The knock-
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out of CTCF gene in murine oocytes prevented the nor-
mal development of the blastocyst after the fertilization
[21].
The functional properties of CTCF. CTCF binding
site. The development of such technologies as ChIP-
chip (chromatin immunoprecipitation on chip) and ChIP-
seq (chromatin immunoprecipitation-sequencing) [22–
24] allowed obtaining a number of consensus DNA se-
quences that CTCF binds preferentially [22, 23, 25]. It
was revealed that both the amino acid sequence of CTCF
protein and the nucleotide sequence of its binding site
are highly conserved in different kinds of vertebrates.
Later the ChIP-seq procedure was expanded with the
exonuclease treatment (ChIP-exo) [26], which secured
more precise localization of CTCF binding sites in the
genome. It was demonstrated that CTCF binding site
may be subdivided into four blocks, each having its own
consensus sequence. About half of CTCF binding sites
contained only two central blocks. Other CTCF binding
sites contained either all the four blocks or the combina-
tion of two or three blocks, or just one block. Further
studies led to the notion of the CTCF core binding mo-
tif [27], which is a base of the majority of binding sites
(Fig. 1).
CTCF binding sequences always include a small
number of sequences without any detectable consensus
[26, 27]. These sequences are assumed to bind CTCF
via intermediate proteins rather than directly [27]. Expe-
rimentally detected CTCF binding sequences are collec-
ted in the CTCF Binding Sites Database [28].
The interaction of CTCF and DNA. The electropho-
retic mobility shift assay (EMSA) was used to study the
interaction of CTCF zinc finger domain fragments and
some known CTCF binding sequences, including the si-
te from chicken beta-globin locus [8], sites from muri-
ne Igf2/H19 locus [29, 30] and site APBbeta, located in
the promoter of human beta-amyloid precursor [31].
Since zinc fingers are a characteristic DNA-binding
structure of many nuclear proteins [32], it was assumed
that the ZnF-containing domain is responsible for the
CTCF-DNA interaction. It was demonstrated that four
zinc fingers (from 4 to 7) are the minimal set required for
the specific interaction of CTCF and its binding site in
vitro. Further reduction in the number of zinc fingers
resulted in a sharp decrease in the DNA-binding ability
of the CTCF fragment [30].
CTCF may use different combinations of zinc fin-
gers for binding to DNA. In particular, the binding to the
regulatory site of chicken MYC gene is effected by zinc
fingers from 2 to 7, while the site located close to P2
promoter of human gene MYC is bound by CTCF via
zinc fingers from 3 to 11 [11]. The binding of chicken
lysozyme silencer fragment F1 in vitro requires zinc fin-
gers from 5 to 8 [7].
Later these data were confirmed and expanded using
mass sequencing [27]. It was demonstrated that the zinc
finger eight is not required for the specific recognition
of the binding site by CTCF and rather stabilizes the
CTCF-DNA complex via unspecific interaction. Zinc
fingers 9–11 are responsible for the interaction with a
small region of CTCF binding sequence separated by
the spacer from the core unit. This fragment, called a U-
element (upstream element), corresponds to the block 1
identified in [26]. It is noteworthy that the removal of
zinc fingers 8–11 leads to the complete lack of the
CTCF interaction with the binding site containing the
U-element [27]. It is likely that when a core sequence is
far from the consensus, a DNA-protein complex is stab-
le only in case of additional interaction of CTCF and the
U-element. Zinc finger 3 is involved in the interaction
with DNA in the absence of the U-element, while zinc
fingers 1 and 2 are likely to not participate in the speci-
fic interaction with DNA, but are responsible for the
overall stabilization of the DNA-protein complex.
The hypothetical mechanisms of the loop formation
(Fig. 2), via which CTCF may participate in the forma-
tion of the chromatin domains and function as a protein
component of insulators are suggested [33, 34].
The impact of DNA CpG methylation on the CTCF
binding. It was demonstrated that CpG methylation of
the CTCF binding sites leads to the suppression of their
binding to CTCF protein in vitro [30, 35–37]. Additio-
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Fig. 1. The general nucleotide structure of the CTCF binding site [27].
The arrows show the potential sites of CpG methylation
nally, CTCF does not bind to the methylated ICR re-
gion of the paternal allele locus in vivo [38, 39], and
CTCF binding to ICR of Igf2/H19 locus of the maternal
chromosome hinders its methylation in course of the or-
ganism development [39].
Wang et al. [40] investigated the in vivo differential
methylation of CTCF binding sequences in 19 types of
cultured cells and human tissues using ChIP-seq and
mass bisulfite sequencing. 36 % of CTCF binding sites
were occupied in all 19 types of cells. The inverse rela-
tion between the degree of methylation and the ability
of binding CTCF was demonstrated for 67 % of diffe-
rentially methylated CTCF binding sites. Therefore,
DNA methylation is an important factor defining CTCF
protein binding to a certain nucleotide sequences. It was
also demonstrated that about 29 % of CTCF binding
sequences in the genome contain CpG at least in one of
two positions – 1 and 11, which corresponds to the posi-
tions 4 and 14 of the core sequence of the CTCF bin-
ding site (Fig. 1, see [27]) and positions –5 and 5 [26].
Interaction of CTCF with proteins. During the im-
munoprecipitation from the cell lysate, CTCF is co-ex-
tracted with a nucleolar protein nucleophosmin. On the
other hand, the method of chromatin immunoprecipita-
tion with antibodies to nucleophosmin was used to de-
monstrate the interaction of the latter with CTCF-de-
pendent insulators in vivo [41]. The chromodomain-
containing helicase CHD8 also binds to CTCF and
CTCF-dependent insulators. In the absence of CHD8
the ICR region of the Igf2/H19 locus ceases its insula-
tory function, although the binding of CTCF to this re-
gion is preserved [42]. The protein complexes of the
CTCF-dependent insulators were demonstrated to con-
tain a large subunit of RNA-polymerase II with the
phosphorylated and dephosphorylated C-terminal do-
main [43].
The co-immunoprecipitation allowed determining
the interaction of CTCF and the DNA-binding protein
YY1. N-terminal domain of CTCF is likely to participa-
te in the interaction. The interaction of CTCF and YY1
is required for the inactivation of one X-chromosome
in order to support the active state of the second X-chro-
mosome [44].
To date, using different methods, more proteins ca-
pable of interacting with CTCF were detected. YB1 (Y-
box-binding protein 1) is a multifunctional DNA- and
RNA-binding protein participating in the regulation of
DNA replication and reparation, transcription, RNA
processing, and capable of interacting with YY1 [45].
Kaiso is a transcription factor, capable of binding DNA
regions with the increased content of methylated CpG-
sites. Possibly, it is capable of replacing CTCF in case of
methylation of site of the binding of the latter [46]. The
transcription corepressor Sin3A [47], histone H2A.Z
[22, 41], PARP [48], p68 (DDX5) [49] and other pro-
teins [2, 50] also interact with CTCF protein.
Another important protein interacting with CTCF
is cohesin. Cohesin is responsible for holding together
sister chromatids required for successful mitosis and
meiosis [51–53]. Cohesin is a protein complex consis-
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Fig. 2. The hypothetical model of the CTCF-mediated loop formation: A – the CTCF binding to its site (shown with an arrow) by means of a subset
of its zinc fingers; B – using a subset of zinc fingers the protein binds to its site, the remaining zinc fingers are available for the loop formation
(DNA bends while binding CTCF which allows the available zinc fingers to close the loop [33]); C – the formation of a loop by means of two
CTCF molecules binding with two sites, located at the borders of the functional domain (the formation is possible with and without the inter-
mediate protein (a green oval); free zinc fingers may participate in the protein-protein interactions [20, 34]; the regions within the box correspond
to the insulators or border elements of the domain)
ting of four subunits: Smc1, Smc3, Scc1 (Rad21) and
Scc3 (SA1 or SA2). Four subunits form a ring structure,
which, most likely, encircles and holds chromatids to-
gether [54]. Cohesin is known to be responsible for the
interaction of sister chromatids, required for successful
mitosis and meiosis, and to be involved in the regula-
tion of the gene expression [55–57]. The ChIP-seq ana-
lysis demonstrated that about half of cohesin binding
sites overlap with the CTCF binding sites [58–60]. Co-
hesin binds to the region in the C-terminal part of CTCF
via its SA2 subunit [61].
The spatial proximity of the regions of interphase
chromatin which simultaneously interact with cohesin
and CTCF was demonstrated using 3C (chromosome con-
formation capture) method. The region of the chromo-
some between the cohesin binding sites forms a loop [56].
The role of the transcription factor CTCF in the
regulation of DNA-dependent processes. The CTCF
binding to DNA may impact the gene expression in dif-
ferent ways: in some cases CTCF acts as transcription
activator, in others – as repressor or ensures the insula-
tor activity.
Insulators are DNA fragments hindering the inter-
action of the regulatory elements between which they
are located. In particular, when located between the pro-
moter and enhancer, the insulator blocks the activating
impact of the latter, whereas on the borders of the gene-
tic construction integrated in the eukaryotic genome
DNA it suppresses the position effect [62]. All known
vertebrate insulators, with rare exceptions [63], bind
transcription factor CTCF.
Additionally, CTCF protein participates in the inac-
tivation of X-chromosome, the imprinting of genetic in-
formation and is likely to regulate the process of RNA
splicing. The development of new methods to study the
interactions between remote regions of the eukaryotic
genome allowed obtaining multiple evidences of a vital
role of CTCF in the formation of a three-dimensional
structure of the eukaryotic genome [34, 64–68]. The un-
derstanding of the mechanisms of such numerous and
various functions of CTCF protein could clear up its ro-
le in the regulation of DNA-dependent processes.
The hypothesis on the functional domains of chro-
matin. Insulators. In the late 80s of 20th century a hypo-
thesis was put forward that all the chromatin of the eu-
karyotic cell is subdivided into structural/functional do-
mains. It stated that a chromatin domain is a loop contai-
ning one or several genes, the ends of which are attach-
ed to the nuclear matrix. For each loop, an independent
supercoiling of DNA is typical. The chromatin of one
domain, regardless of the chromatin of other domains,
may pass into open (transcriptionally active) or closed
(inactive) conformation [69, 70].
Since the formulation of the chromatin domains hy-
pothesis, numerous data were obtained that support, ela-
borate and amend this hypothesis. At present, it is estab-
lished that the main factor controlling the chromatin fi-
ber decompactization and, hence, the possibility to start
transcription at the given chromosome region, is the ace-
tylation of histones [71, 72]. The locus control regions
(LCRs), i. e. DNA regions determining the transcrip-
tional status of the domain, have been defined [73–75].
The study of the chicken beta-globin locus demonst-
rated that in the beta-globin expressing cells the chro-
matin of the locus is in the decompacted state, the level
of histone acetylation is increased. At the same time the
chromatin outside the locus is in the condensed state
[76–78]. The ends of the beta-globin locus interact with
the nuclear matrix and are close to each other, and the
locus forms a loop [79–83]. It was also demonstrated
that the loops may be formed not only by bringing toge-
ther functional domains ends, but also by joining speci-
fic DNA regions, for instance enhancers and promoters,
inside the same domain [81, 84, 85].
Recently it has been established that the transcrip-
tional activity of the gene depends on both the regula-
tory elements inside the domain and the location of this
gene in a specific part of the nucleus [64-68]. The gene
may also be exposed to the regulatory elements located
in other domains and even on other chromosomes [86–
88]. Therefore, the amended and elaborated hypothesis
of the structural/functional chromatin domains remains
viable.
Given the chromatin domains, there should be func-
tional elements, which protect the genes of one domain
against an impact of the regulatory elements of other do-
mains. These functional elements of the genome are in-
sulators [89, 90]. Insulators prevent undesirable activa-
tion or repression of genes under the impact of the en-
vironment. The undesirable gene activation by the en-
hancer is suppressed via blocking its effect on the pro-
moter only in case when the insulator is located between
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them. The insulator also prevents the undesirable gene
repression by limiting the expansion of the condensed
chromatin along the chromatin fiber [89, 91]. Some au-
thors call insulators the border elements, since they are
often located at the borders of domains (Fig. 2) [92].
The prevailing majority of insulators found in the
vertebrate genomes are capable of binding the transcrip-
tion factor CTCF [8, 63, 89]. CTCF plays a vital role in
the formation of chromatin loops. It was demonstrated
that in vertebrate beta-goblin loci the CTCF binding si-
tes located at the borders of loci are in contact with each
other [80, 81, 93], and no activation of the promoters in
the adjacent domains by the locus enhancers is detected
in the beta-globin expressed cells. Similarly, the regula-
tory elements of the adjacent domains do not affect the
expression of globin genes in erythroid cells [76–78,
94, 95].
The analysis of the human genome showed that the
distribution of CTCF binding sites strongly correlates
with the density of the genes, but weakly correlates
with the lengths of chromosomes [24]. Despite the de-
pendence of the number of CTCF binding sites on the
number of genes, the great part of these sites (46 %) is
located very far from promoters, 48 kbp on the average
[24, 96]. It distinguishes the distribution of CTCF bin-
ding sites from the distribution of sites of the majority
of other transcription factors and is in good agreement
with the insulator function of CTCF.
The genome regions depleted of the CTCF binding
sites mostly contain the gene families with the shared re-
gulation of transcription, whereas the domains enriched
for the CTCF binding sites contain the genes with alter-
natively regulated promoters. These observations are
also in agreement with the insulator function of CTCF
[24].
Enhancer blocking. The first data on the enhancer-
blocking properties of CTCF binding sites were obtai-
ned using the constructions containing a promoter-dri-
ven reporter gene and an enhancer. The CTCF binding
sequence was introduced between the enhancer and the
promoter [8; 97]. The analysis of expression of the re-
porter gene in the presence and in the absence of the
CTCF binding site allowed estimating the enhancer-
blocking activity of this DNA fragment. The majority
of CTCF binding sequences demonstrate their enhan-
cer-blocking activity in such constructions during both
the transient transfection and the integration into the
genome [98–100].
The method of estimation of the reporter gene ex-
pression at the transient transfection has some draw-
backs. Normally the CTCF binding sites function as a
part of chromatin, and the plasmid vector does not comp-
letely imitate the chromatin environment.
Additionally, in many cases the plasmid vector is a
heterological system where the enhancer, promoter, CTCF
binding site and the reporter gene may originate from dif-
ferent organisms.
The mechanism of function of the CTCF-depen-
dent insulator was studied using the artificial minichro-
mosome containing the enhancer from human beta-glo-
bin locus LCR and the epsilon-globin gene with its own
promoter [101]. The CTCF-dependent chicken 5'HS4
insulator was cloned between the enhancer and the pro-
moter of epsilon-globin gene, and for the control – close
to the enhancer outside the promoter-enhancer unit.
When the insulator was placed between the enhancer
and promoter, the following effects were demonstra-
ted: the CTCF-dependent enhancer-blocking effect as
well as a CTCF-dependent decrease in the amount of
the promoter-bound RNA-polymerase II and an increa-
se in the amount of polymerase interacting with the en-
hancer and CTCF-binding sequence. This may be ex-
plained by the fact that the CTCF-containing DNA-pro-
tein complex hinders the movement of RNA-polyme-
rase from the enhancer towards the promoter. It was al-
so noted the CTCF-dependent reduction in the acetyla-
tion of histones H3 and H4 between the 5'HS4 insulator
and the gene, including the promoter region, when the
5'HS4 insulator was located between the enhancer and
the promoter [101].
The introduction of several core sequences of the
chicken 5`HS4 insulator into the plasmid construction
between the enhancer and the promoter resulted in a mo-
re pronounced enhancer-blocking effect compared to the
introduction of one sequence [102]. The same effect is
observed while placing between the enhancer and the
promoter several CTCF-dependent insulators HS1 or
HS2 from ICR of the murine Igf2/H19 locus [37, 38].
Therefore, several CTCF-containing DNA-protein
complexes hinder the movement of RNA-polymerase
II from the enhancer to the promoter more efficiently
compared to a single complex.
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However, the signal transmission along the chro-
matin fiber hardly may be considered as the only mecha-
nism of the enhancer functioning. Many enhancers are
separated from their target promoters by millions of ba-
se pairs [103], and the enhancer and the promoter are of-
ten separated by several chromosome loci with different
chromatin structures. Moreover, the activation of the
promoter by the enhancer located on the other chromo-
some is described [86, 88].
Some authors believe that this mechanism is reali-
zed only in enhancer-like elements of prokaryotes and
not in case of real eukaryotic enhancers [104].
Recently, using the 3C (chromosome conformation
capture) technology and its extensions [105], the direct
interaction of the enhancer with the corresponding pro-
moter was demonstrated [106, 107]. However, it is still
unknown the mechanism of promoter activation via the
chromatin loop formation and bringing the enhancer and
the promoter closer to each other [108]. Possibly, the
promoter is drawn into the nuclear compartment with
the conditions for the active transcription [108]. The
ability to stabilize the chromatin loops was demonstra-
ted for different proteins, including CTCF, by the ChIA-
PET method [34, 87].
According to the decoy model [62, 109], the CTCF-
binding insulators may compete with the promoters for
the interaction with enhancers, i. e. they may trap the en-
hancer not allowing its binding to the promoter. It was
demonstrated [34] that a significant number of CTCF
binding sequences participating in remote interactions
are bound to the sequences with the enhancer proper-
ties. On the other hand, if an insulator functions as a de-
coy, there should be some signal transmission between
the enhancer and the promoter along the chromatin fi-
ber, otherwise the decoy would have the same effect re-
gardless of its position relative to the enhancer which
is in contradiction to the insulator definition. The 3C
method was used in beta-globin loci of vertebrates to
show that the enhancers and promoters are in close phy-
sical proximity [80], which is the evidence of the enhan-
cer functioning via the combined tracking-looping
mechanism.
Insulator as a border element. During the intro-
duction of the transgene-containing constructs into the
genome, the transgene expression initially occurs at ap-
proximately the same level in all the cells, but later the
majority of the constructs inserted into the genome be-
come inactive due to the chromatin condensation. This
inhibition is reversible in Drosophila and yeast, but in
vertebrates it becomes irreversible due to DNA methy-
lation [110]. The 5'HS4 insulator, located at the 5'-end
of the beta-globin locus, hinders the spreading of the ad-
jacent area of the condensed chromatin over the whole
locus.
It was demonstrated by the ChIP method [111] that
some CTCF binding sites are located in the regions of
the transition of the compacted chromatin to the decom-
pacted state. These regions were detected by the change
in the level of trimethylation of the histone H3 lysine
27 (H3K27me3) and acetylation of the lysine 5 of histo-
ne H2A (H2AK5ac). The modification H3K27me3 is
characteristic for the compact chromatin and H2AK5ac –
for the decompacted one. The portion of the CTCF bin-
ding sequences located in the regions of transition of
the compacted chromatin into the decompacted state is
small, but non-random distribution of these sequences
was demonstrated with high significance. It evidences
for the probable role of the CTCF binding sites in the
separation of the chromosome domains in vivo.
A considerable enrichment of the border regions of
so called topological domains for the CTCF binding
sites was demonstrated [112]. The authors assumed
that the border regions of the topological domains may
represent the insulators blocking the expansion of hete-
rochromatin. Indeed, the border elements of the topolo-
gical domains in the differentiated cells correspond to
the regions with the reduced level of H3K9me, characte-
ristic for the transformation of heterochromatin into a
less compact state. During the formation of the final
structure of the genome domains the stabilization of the
chromatin state is likely to occur after the formation of
the loop structure.
The CTCF binding sequences may not be directly
involved in the blocking of the heterochromatin expan-
sion. However, the distinct division of the regions of
compacted and decompacted chromatin in the genome
may be a result of the formation of the loop structures by
the CTCF-containing border elements.
CTCF as a transcription regulator. CTCF is capab-
le of both activating and inhibiting transcription depen-
ding on the target gene. The mechanisms of the activa-
tion may be different. Firstly, CTCF may act as a trans-
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cription factor promoting or hindering the formation of
the initiator complex. In other cases the binding of
CTCF may result in the formation/destruction of the
chromatin domain with the corresponding change in the
chromatin structure, which, in turn, leads to the change
in the genes expression in this domain. It should be no-
ted that it is not always easy to discriminate between
these mechanisms. According to the first mechanism,
gene MYC is likely to be repressed [5], whereas to the
second – gene PUMA [113]. Some examples of the re-
gulation involving CTCF are presented below.
The binding of CTCF to 5'-regulatory region of
APP (amyloid  protein precursor) gene resulted in the
activation of this gene promoter at transcription in vitro
in the nuclear extract of HeLa cells [31, 114]. The ad-
dition of oligonucleotides, competing for CTCF bin-
ding, to the nuclear extract led to a decrease of the pro-
moter activity. The same effect was observed when
CTCF was removed from the nuclear extract via immu-
noprecipitation, but the addition of the CTCF protein to
the depleted nuclear extract restored the activity of the
promoter. The region of CTCF protein between the ami-
no acid residues 1 and 248 is responsible for the activa-
tion [114].
It was demonstrated that the HS5-1 DNA region,
hypersensitive to DNase I and located in the cluster of
protocadherin genes, has properties of the enhancer
[115] and, according to the chromatin immunoprecipi-
tation data, interacts with CTCF in the murine brain
cells. The deletion of this CTCF binding sequence from
the genome of transgene mice leads to the reduction in
the promoter activity [116]. Chromatin immunoprecipi-
tation with subsequent mass sequencing demonstrated
that CTCF and cohesin interact with the promoter of al-
ternative forms of protocadherin alpha. The binding di-
rectly correlates with the expression of alternative iso-
forms [117]. The 3C method was used to demonstrate
the spatial proximity of the promoters of alpha-proto-
cadherins 4, 8 and 12, and the potential enhancers HS5-
1 and HS7 [84].
The chicken lysozyme silencer consists of two
modules F1 and F2. Module F2 binds to the receptor of
thyroid hormones, whereas F1 contains the CTCF bin-
ding site, and both modules can suppress transcription
independently of each other. When each of them binds
its protein factor, their activity is synergized [6]. Pos-
sibly, the mechanism of suppression-activation of the
chicken lysozyme gene involves the co-suppressor Sin3A
and the histone acetylase and deacetylase complexes
[47, 91, 118].
The interaction of CTCF with two CpG-islands in
the first intron of Bcl6 gene does not allow this gene to
be actively expressed. These CpG-islands are methyla-
ted in some lymphomas, which prevents CTCF binding
to DNA and leads to an increase in the cellular Bcl6
mRNA level [119].
Binding CTCF to the site in the first exon of human
telomerase gene hTERT inhibits its transcription. The
methylation of CTCF binding sequence is likely to play
a vital role in the regulation of this gene expression.
The first exon of the telomerase gene within the plas-
mid construction has a suppressing effect on some pro-
moters in the cells both expressing and not expressing
telomerase. In the telomerase-expressing cells, it is ob-
served the methylation of the CTCF binding sequence
in the first exon and the absence of CTCF binding [120].
After treatment with 5-aza-2'-deoxycytidine, lea-
ding to the DNA demethylation, the binding of CTCF
to the site in the first exon of the hTERT gene and the
inhibition of its mRNA synthesis are observed in the
cell lines expressing hTERT. The inhibition of CTCF
expression using short hairpin RNAs led to an increase
in the level of the hTERTmRNA in the cells [120; 121].
CTCF participation was also noticed in the trans-
cription regulation of Bax [122], tumor repressor p16
[123], and the ribosomal RNA genes [124].
The participation of CTCF protein in the imprin-
ting of genetic information. The gene imprinting is defi-
ned as the way of inheritance, when only one parental
allele of the gene is expressed in the progeny. The
choice of the allele to be expressed is determined by its
origin from either the paternal or maternal organism.
CTCF interacts with the DNA region that controls the
imprinting (imprinting control region, ICR). The most
studied example of CTCF participation in the imprin-
ting is the regulation of the genes of the mouse Igf2/
H19 locus [37, 125]. Igf2 (insulin-like growth factor 2)
gene encodes the embryonic mitogen [37], from H19
gene the non-coding RNA is transcribed, slowing down
the fetal growth [62, 126, 127]. The expression of Igf2
occurs only from the paternal chromosome, H19 – only
from the maternal due to the ICR located between these
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genes. ICR on the maternal chromosome of mice con-
tains two sites capable of binding CTCF and having the
insulator properties. ICR on the paternal chromosome
is methylated regardless of the tissue and the stage of
development and is not capable of binding CTCF. The-
refore, the CTCF-dependent insulators on the paternal
chromosome are inactive, the promoter freely interacts
with the enhancers and Igf2 is expressed [128].
While interacting with ICR of the maternal chro-
mosome, CTCF is likely to protect the adjacent regions
of the locus, including the promoter and the inner re-
gions of gene H19, from the methylation. If the mater-
nal ICR is mutated and does not bind CTCF, the me-
thylation spreads to the promoter and the intragenic re-
gions of H19, and the expression of this gene decreases
[129, 130]. Therefore, by the inhibiting of the CTCF
binding, the methylation of the paternal ICR leads to
the methylation of the promoter of H19 gene and the in-
hibition of the expression of the paternal allele [129–
131].
CTCF and the inactivation of X-chromosome. CTCF
participates in the inactivation of the mammalian X-
chromosome [132]. The X-chromosome contains the
X-inactivation center (Xic) that controls the inactiva-
tion of one X-chromosome in each cell during the emb-
ryogenesis and the maintenance of its silenced state.
Xic includes genes Xist (X-inactive specific trans-
cript), Tsix (the name comes from the reverse of Xist,
which reflects the reverse orientation of the Tsix gene
regarding to Xist) and Xite (X-inactivation intergenic
transcription element), from which the non-coding
RNAs are transcribed. The X-chromosome, where the
actively expressing allele of Xist is located, is inacti-
vated. The transcription of Tsix and Xite genes occurs
from the active X-chromosome. The transcript of Tsix
inactivates the expression of Xist located on the same
chromosome, and the expression of Xite activates the
expression of Tsix, which leads to the inhibition of the
expression of Xist, resulting in maintenance of the
activity of the X-chromosome with transcriptionally
active Tsix and Xite alleles [50, 133].
The process of X-inactivation is realized in several
stages [133–136]. First, the «counting» of the number
of X-chromosomes in the cell, or rather the determina-
tion of the ratio between the number of X-chromoso-
mes and autosomes [133, 134]. The next stage is the
homologous pairing of two X-chromosomes and choi-
ce of the one to be inactivated. The interaction between
X-chromosomes takes place in the Xic region, and for
the pairing of X-chromosomes the fragment of Xic con-
taining Xite and Tsix genes is required [137, 138]. This
region is rich in the binding sites of CTCF as well as
protein YY1 [44, 132, 139]. It was demonstrated that in
the absence of CTCF in the cell the pairing of X-chro-
mosomes is suppressed. Protein YY1, capable of inter-
acting with CTCF, is not required at this stage [139]. A
model is proposed according to which the pairing of
X-chromosomes leads to irreversible transfer of protein
factors like CTCF and Oct-4 from one X-chromosome
(later inactive) to the other (later active) [44, 138–142].
If this model is accurate, CTCF protein is also involved
in the selection of the X-chromosome to be inactivated.
The last stage is just the process of X-chromosome in-
activation. As a result of active expression of Xist gene,
the Xist transcript covers the chromosome where it was
synthesized, and the chromatin of this X-chromosome
becomes compacted [134–136].
The process of X-chromosome inactivation invol-
ves the interaction of the repressor complex PRC2 with
5'-region of Xist gene as well as the enrichment of chro-
matin of this region in trimethylated lysine 27 histone
H3 [143, 144]. The inactivation of X-chromosome re-
quires the transcription of a small region of Xist into
RepA RNA [145, 146]. RepA is likely to interact with
the PRC2 complex [144]. It was demonstrated that X-
chromosome containing in the Xist promoter the CTCF
binding site with the enhanced affinity to this protein is
inactivated more often than X-chromosome where this
DNA fragment has lower affinity to CTCF [147]. Along
with YY1, CTCF is likely to participate in the activa-
tion of the Tsix gene expression [44]. CTCF also ensu-
res the functioning of insulator elements, separating the
active genes on the inactivated X-chromosome from
the transcriptionally non-active environment [148].
The co-transcriptional regulation of the alternative
splicing. Recently some evidences have been found of
the fact that CTCF may be involved in the co-trans-
criptional regulation of the alternative splicing. It was
demonstrated that the interaction of CTCF with the
DNA fragment located in the fifth exon of CD45 gene
leads to a more frequent inclusion of this exon into the
mature mRNA. CTCF depletion in the cell by RNA-in-
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terference, or methylation of the CTCF binding site in
the fifth exon of CD45 gene resulted in the inhibition of
the formation of a splice form containing the fifth exon.
It was shown that CTCF binding to this site leads to
RNA-polymerase II pausing within the region of CTCF
binding. The comparison of the genome-wide chroma-
tin immunoprecipitation data obtained with antibodies
to CTCF and RNA-polymerase II and the data of the
transcriptome analysis confirmed that the CTCF protein
bound to DNA detains the transcribing RNA-poly-
merase II [149, 150].
These data were used to suggest the hypothesis on
the role of the CTCF protein in the regulation of the al-
ternative splicing. The initial stages of RNA splicing
take place during the transcription, and the preferential
development of a splice form may depend on the elon-
gation rate. If in the transcript, after the occurrence of a
relatively weak splice-site, but prior to the occurrence
of a more strong one, the RNA-polymerase II is detained
by the CTCF protein, bound to DNA, a weaker splice-
site will gain an advantage. Thus, the CTCF protein
may affect the elongation rate and regulate the alterna-
tive splicing [149, 151].
Conclusions. The main functions of CTCF, studied
thus far, are as follows:
– the direct regulation of transcription of some genes;
– the organization of the domain structure of chro-
matin;
– the organization of insulators (enhancer-blocking
and border elements);
– the participation in the genome imprinting and in-
activation of X-chromosome;
– the regulation of the alternative splicing.
In most cases the accurate mechanism of these
functions is yet to be studied.
A great number and variety of the CTCF binding
sites, the multitude of its functions and the fact that
CTCF is present only in relatively developed metazoa
and is absent in plants and protozoa, suggest that its
main task is to regulate the organism development and
to organize the cellular genome so that it could be a con-
stituent of a multicellular organism.
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Ôàêòîð òðàíñêðèïö³¿ CTCF ³ îðãàí³çàö³ÿ ãåíîìó ññàâö³â
Î. C. Êîòîâà, Ñ. Á. Àêîïîâ, ª. Ä. Ñâåðäëîâ, Ë. Ã. Í³êîëàºâ
Ðåçþìå
Ôàêòîð òðàíñêðèïö³¿ CTCF ââàæàþòü îäíèì ç îñíîâíèõ ó÷àñíè-
ê³â ð³çíèõ ìåðåæ ðåãóëÿö³¿ ãåí³â, ç-ïîì³æ ÿêèõ àêòèâàö³ÿ ³ ðåï-
ðåñ³ÿ òðàíñêðèïö³¿, óòâîðåííÿ íåçàëåæíî ôóíêö³îíóþ÷èõ äîìåí³â
õðîìàòèíó, ðåãóëÿö³ÿ ³ìïðèíòèíãó òîùî. Ñåêâåíóâàííÿ ãåíîì³â
ëþäèíè òà ³íøèõ îðãàíèçì³â äîçâîëÿº âèÿâëÿòè ãåíîìíèé ðîçïî-
ä³ë ñàéò³â çâ’ÿçóâàííÿ CTCF òà ³äåíòèô³êóâàòè CTCF-çàëåæí³
ðåãóëÿòîðí³ åëåìåíòè, äî ÿêèõ íàëåæàòü ³íñóëÿòîðè. Â îãëÿä³
ï³äñóìîâàíî íîâ³ äàí³ ç ôóíêö³îíóâàííÿ CTCF ó ðàìêàõ ã³ïîòåçè
ó÷àñò³ ïåòåëüíèõ äîìåí³â õðîìàòèíó ó âåëèêîìàñøòàáí³é ðåãó-
ëÿö³¿ àêòèâíîñò³ ãåíîìó. Ôóíäàìåíòàëüí³ âëàñòèâîñò³ CTCF äî-
çâîëÿþòü éîìó ä³ÿòè ÿê ðåãóëÿòîð òðàíñêðèïö³¿, ³íñóëÿòîðíèé
á³ëîê, à òàêîæ ÿê ðîçïîä³ëåíèé ïî ãåíîìó ïðèêîðäîííèé åëå-
ìåíò,çäàòíèé çàëó÷àòè ð³çí³ ôàêòîðè, ÿê³ ç’ÿâëÿþòüñÿ ó â³äïî-
â³äü íà ð³çíîìàí³òí³ çîâí³øí³ òà âíóòð³øí³ ÷èííèêè ³ òàêèì ÷è-
íîì âèêîíóâàòè ñâî¿ ñèãíàë-ñïåöèô³÷í³ ôóíêö³¿.
Êëþ÷îâ³ ñëîâà: ôàêòîð òðàíñêðèïö³¿ CTCF, õðîìàòèí, ðåãó-
ëÿö³ÿ òðàíñêðèïö³¿.
Ôàêòîð òðàíñêðèïöèè CTCF è îðãàíèçàöèÿ ãåíîìà
ìëåêîïèòàþùèõ
E. C. Êîòîâà, Ñ. Á. Àêîïîâ, Å. Ä. Ñâåðäëîâ, Ë. Ã. Íèêîëàåâ
Ðåçþìå
Ôàêòîð òðàíñêðèïöèè CTCF ñ÷èòàåòñÿ îäíèì èç îñíîâíûõ ó÷à-
ñòíèêîâ ðàçëè÷íûõ ñåòåé ðåãóëÿöèè ãåíîâ, âêëþ÷àÿ àêòèâàöèþ è
ðåïðåññèþ òðàíñêðèïöèè, îáðàçîâàíèå íåçàâèñèìî ôóíêöèîíèðó-
þùèõ äîìåíîâ õðîìàòèíà, ðåãóëÿöèþ èìïðèíòèíãà è ò. ä. Ñåêâå-
íèðîâàíèå ãåíîìîâ ÷åëîâåêà è äðóãèõ îðãàíèçìîâ ïîçâîëÿåò âûÿ-
âèòü ãåíîìíîå ðàïðåäåëåíèå ñàéòîâ ñâÿçûâàíèÿ CTCF è èäåíòè-
ôèöèðîâàòü CTCF-çàâèñèìûå ðåãóëÿòîðíûå ýëåìåíòû, âêëþ÷àÿ
èíñóëÿòîðû. Â îáçîðå ñóììèðîâàíû íîâûå äàííûå ïî ôóíêöèîíè-
ðîâàíèþ CTCF â ðàìêàõ ãèïîòåçû ó÷àñòèÿ ïåòåëüíûõ äîìåíîâ
õðîìàòèíà â êðóïíîìàñøòàáíîé ðåãóëÿöèè àêòèâíîñòè ãåíîìà.
Ôóíäàìåíòàëüíûå ñâîéñòâà CTCF ïîçâîëÿþò åìó äåéñòâîâàòü
êàê ðåãóëÿòîð òðàíñêðèïöèè, èíñóëÿòîðíûé áåëîê, à òàêæå êàê
ðàñïðåäåëåííûé ïî ãåíîìó ïîãðàíè÷íûé ýëåìåíò, ñïîñîáíûé ïðè-
âëåêàòü ðàçëè÷íûå ôàêòîðû, ïîÿâëÿþùèåñÿ â îòâåò íà ðàçíîîá-
ðàçíûå âíåøíèå è âíóòðåííèå âîçäåéñòâèÿ è òàêèì îáðàçîì îñó-
ùåñòâëÿòü ñâîè ñèãíàë-ñïåöèôè÷íûå ôóíêöèè.
Êëþ÷åâûå ñëîâà: ôàêòîð òðàíñêðèïöèè CTCF, õðîìàòèí, ðå-
ãóëÿöèÿ òðàíñêðèïöèè.
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